Pregled bibliografske jedinice broj: 1195812
In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery
In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery // European journal of pharmaceutics and biopharmaceutics, 175 (2022), 27-42 doi:10.1016/j.ejpb.2022.04.009 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1195812 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
In situ gelling nanosuspension as an advanced
platform for fluticasone propionate nasal delivery
Autori
Nižić Nodilo, Laura ; Perkušić, Mirna ; Ugrina, Ivo ; Špoljarić, Drago ; Jakobušić Brala, Cvijeta ; Amidžić Klarić, Daniela ; Lovrić, Jasmina ; Saršon, Vesna ; Safundžić Kučuk, Maša ; Zadravec, Dijana ; Kalogjera, Livije ; Pepić, Ivan ; Hafner, Anita
Izvornik
European journal of pharmaceutics and biopharmaceutics (0939-6411) 175
(2022);
27-42
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
in situ gelling ; nanosuspension ; fluticasone propionate ; nasal drug delivery ; 3D printed nasal cavity model ; chronic rhinosinusitis
Sažetak
In this work we present the development of in situ gelling nanosuspension as an advanced form for fluticasone propionate nasal delivery. Drug nanocrystals were prepared by wet milling technique. Incorporation of drug nanocrystals into polymeric in situ gelling system with pectin and sodium hyaluronate as constitutive polymers was fine-tuned attaining appropriate formulation surface tension, viscosity and gelling ability. Drug nanonisation improved the release profile and enhanced formulation mucoadhesive properties. QbD approach combining formulation and administration parameters resulted in optimised nasal deposition profile, with 51.8% of the dose deposited in the middle meatus, the critical region in the treatment of rhinosinusitis and nasal polyposis. Results obtained in biocompatibility and physico- chemical stability studies confirmed the leading formulation potential for safe and efficient nasal corticosteroid delivery.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Projekti:
HRZZ-UIP-2017-05-4592 - Optimiranje depozicije raspršenih in situ gelirajućih i praškastih terapijskih sustava u nosnoj šupljini (OptiNasalSpray) (Hafner, Anita, HRZZ - 2017-05) ( CroRIS)
EK-EFRR-KK.01.1.1.02.0021 - Jačanje znanstveno-istraživačkih i inovacijskih kapaciteta Farmaceutsko-biokemijskog fakulteta Sveučilišta u Zagrebu (FarmInova) (Lovrić, Jasmina, EK - Ulaganje u organizacijsku reformu i infrastrukturu u sektoru istraživanja, razvoja i inovacija) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Stomatološki fakultet, Zagreb,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Prirodoslovno-matematički fakultet, Split
Profili:
Dijana Zadravec (autor)
Anita Hafner (autor)
Ivan Pepić (autor)
Livije Kalogjera (autor)
Daniela Amidžić Klarić (autor)
Laura Nižić Nodilo (autor)
Ivo Ugrina (autor)
Mirna Perkušić (autor)
Maša Safundžić Kučuk (autor)
Jasmina Lovrić (autor)
Drago Špoljarić (autor)
Cvijeta Jakobušić Brala (autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE